United States Xarelto Market Report 2016

Publisher Name :
Date: 10-Oct-2016
No. of pages: 123
Inquire Before Buying

Notes:

Sales, means the sales volume of Xarelto

Revenue, means the sales value of Xarelto

This report studies sales (consumption) of Xarelto in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Pfizer, Inc. (US)

- Bayer Healthcare AG (Germany)

- GlaxoSmithKline Plc. (UK)

- Boehringer Ingelheim (Germany)

- Sanofi S.A. (France)

- Abbott India Limited (India)

- Aspen Holdings (South Africa)

- Bristol-Myers Squibb Company (US)

- Eisai Inc. (US)

- Mitsubishi Tanabe Pharma Corporation (Japan)

- Teva Pharmaceutical Industries Ltd. (Israel)

Split by product Types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Xarelto in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Xarelto Market Report 2016

Table of Contents
United States Xarelto Market Report 2016
1 Xarelto Overview
1.1 Product Overview and Scope of Xarelto
1.2 Classification of Xarelto
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Xarelto
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Xarelto (2011-2021)
1.4.1 United States Xarelto Sales and Growth Rate (2011-2021)
1.4.2 United States Xarelto Revenue and Growth Rate (2011-2021)
2 United States Xarelto Competition by Manufacturers
2.1 United States Xarelto Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Xarelto Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Xarelto Average Price by Manufactures (2015 and 2016)
2.4 Xarelto Market Competitive Situation and Trends
2.4.1 Xarelto Market Concentration Rate
2.4.2 Xarelto Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Xarelto Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Xarelto Sales and Market Share by Type (2011-2016)
3.2 United States Xarelto Revenue and Market Share by Type (2011-2016)
3.3 United States Xarelto Price by Type (2011-2016)
3.4 United States Xarelto Sales Growth Rate by Type (2011-2016)
4 United States Xarelto Sales (Volume) by Application (2011-2016)
4.1 United States Xarelto Sales and Market Share by Application (2011-2016)
4.2 United States Xarelto Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Xarelto Manufacturers Profiles/Analysis
5.1 Pfizer, Inc. (US)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Xarelto Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Pfizer, Inc. (US) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Bayer Healthcare AG (Germany)
5.2.2 Xarelto Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Bayer Healthcare AG (Germany) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline Plc. (UK)
5.3.2 Xarelto Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 GlaxoSmithKline Plc. (UK) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Boehringer Ingelheim (Germany)
5.4.2 Xarelto Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Boehringer Ingelheim (Germany) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Sanofi S.A. (France)
5.5.2 Xarelto Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Sanofi S.A. (France) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Abbott India Limited (India)
5.6.2 Xarelto Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Abbott India Limited (India) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Aspen Holdings (South Africa)
5.7.2 Xarelto Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Aspen Holdings (South Africa) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Bristol-Myers Squibb Company (US)
5.8.2 Xarelto Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Bristol-Myers Squibb Company (US) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Eisai Inc. (US)
5.9.2 Xarelto Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Eisai Inc. (US) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Mitsubishi Tanabe Pharma Corporation (Japan)
5.10.2 Xarelto Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Mitsubishi Tanabe Pharma Corporation (Japan) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Teva Pharmaceutical Industries Ltd. (Israel)
6 Xarelto Manufacturing Cost Analysis
6.1 Xarelto Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Xarelto
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Xarelto Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Xarelto Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Xarelto Market Forecast (2016-2021)
10.1 United States Xarelto Sales, Revenue Forecast (2016-2021)
10.2 United States Xarelto Sales Forecast by Type (2016-2021)
10.3 United States Xarelto Sales Forecast by Application (2016-2021)
10.4 Xarelto Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Xarelto
Table Classification of Xarelto
Figure United States Sales Market Share of Xarelto by Type in 2015
Table Application of Xarelto
Figure United States Sales Market Share of Xarelto by Application in 2015
Figure United States Xarelto Sales and Growth Rate (2011-2021)
Figure United States Xarelto Revenue and Growth Rate (2011-2021)
Table United States Xarelto Sales of Key Manufacturers (2015 and 2016)
Table United States Xarelto Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Xarelto Sales Share by Manufacturers
Figure 2016 Xarelto Sales Share by Manufacturers
Table United States Xarelto Revenue by Manufacturers (2015 and 2016)
Table United States Xarelto Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Xarelto Revenue Share by Manufacturers
Table 2016 United States Xarelto Revenue Share by Manufacturers
Table United States Market Xarelto Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Xarelto Average Price of Key Manufacturers in 2015
Figure Xarelto Market Share of Top 3 Manufacturers
Figure Xarelto Market Share of Top 5 Manufacturers
Table United States Xarelto Sales by Type (2011-2016)
Table United States Xarelto Sales Share by Type (2011-2016)
Figure United States Xarelto Sales Market Share by Type in 2015
Table United States Xarelto Revenue and Market Share by Type (2011-2016)
Table United States Xarelto Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Xarelto by Type (2011-2016)
Table United States Xarelto Price by Type (2011-2016)
Figure United States Xarelto Sales Growth Rate by Type (2011-2016)
Table United States Xarelto Sales by Application (2011-2016)
Table United States Xarelto Sales Market Share by Application (2011-2016)
Figure United States Xarelto Sales Market Share by Application in 2015
Table United States Xarelto Sales Growth Rate by Application (2011-2016)
Figure United States Xarelto Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Xarelto Sales Market Share (2011-2016)
Table Bayer Healthcare AG (Germany) Basic Information List
Table Bayer Healthcare AG (Germany) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Healthcare AG (Germany) Xarelto Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table GlaxoSmithKline Plc. (UK) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc. (UK) Xarelto Sales Market Share (2011-2016)
Table Boehringer Ingelheim (Germany) Basic Information List
Table Boehringer Ingelheim (Germany) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim (Germany) Xarelto Sales Market Share (2011-2016)
Table Sanofi S.A. (France) Basic Information List
Table Sanofi S.A. (France) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A. (France) Xarelto Sales Market Share (2011-2016)
Table Abbott India Limited (India) Basic Information List
Table Abbott India Limited (India) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott India Limited (India) Xarelto Sales Market Share (2011-2016)
Table Aspen Holdings (South Africa) Basic Information List
Table Aspen Holdings (South Africa) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aspen Holdings (South Africa) Xarelto Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Company (US) Basic Information List
Table Bristol-Myers Squibb Company (US) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Company (US) Xarelto Sales Market Share (2011-2016)
Table Eisai Inc. (US) Basic Information List
Table Eisai Inc. (US) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eisai Inc. (US) Xarelto Sales Market Share (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information List
Table Mitsubishi Tanabe Pharma Corporation (Japan) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Xarelto Sales Market Share (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Basic Information List
Table Teva Pharmaceutical Industries Ltd. (Israel) Xarelto Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Xarelto Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Xarelto
Figure Manufacturing Process Analysis of Xarelto
Figure Xarelto Industrial Chain Analysis
Table Raw Materials Sources of Xarelto Major Manufacturers in 2015
Table Major Buyers of Xarelto
Table Distributors/Traders List
Figure United States Xarelto Production and Growth Rate Forecast (2016-2021)
Figure United States Xarelto Revenue and Growth Rate Forecast (2016-2021)
Table United States Xarelto Production Forecast by Type (2016-2021)
Table United States Xarelto Consumption Forecast by Application (2016-2021)
  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • 2017-2022 Aberrometer Report on Global and United States Market, Status and Forecast, by Players, Types and Applications
    Published: 25-May-2017        Price: US 2960 Onwards        Pages: 103
    This report studies the Aberrometer market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Aberrometer market by product type and applications/end industries. The global Aberrometer market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 202......
  • Global and Europe Tuberculin Market Research Report 2017
    Published: 25-May-2017        Price: US 4000 Onwards        Pages: 107
    The Global and Europe Tuberculin Market Research Report 2017 is a professional and in-depth study on the current state of the Tuberculin market. This report focuses on top manufacturers in global market, with Sales, price, revenue and market share for each manufacturer, covering Sanofi Pasteur Zoetis Par Sterile SSI Japan BCG Thermo Fisher Sanroad Biological CNBG Market Segment by Regions, this report splits Gl......
  • Global Linear Accelerators for Radiation Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 25-May-2017        Price: US 3480 Onwards        Pages: 121
    Linear Accelerators (for Radiation) is a device that uses high Radio-Frequency (RF) electromagnetic waves to accelerate charged particles (i.e. electrons) to high energies in a linear path, inside a tube like structure called the accelerator waveguide. The resonating cavity frequency of the medical LINACs is about 3 billion Hertz (cycles/sec). This is the most common device to treat cancer with external beam radiation. Scope of the Report: This report focuses on the......
  • 2017-2022 United States Clinical Mass Spectrometry Market Report (Status and Outlook)
    Published: 25-May-2017        Price: US 3360 Onwards        Pages: 114
    "This report will be delivered in 2-3 business days after the order is placed." The Clinical Mass Spectrometry market size will be XX million (USD) in 2022 in United States, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In United States market, the top players include - Thermo Fisher - AB Sciex (Danaher) - Waters - Agilent - Bruker - Perkin Elmer -......
  • 2017-2022 Philippines Clinical Mass Spectrometry Market Report (Status and Outlook)
    Published: 25-May-2017        Price: US 3360 Onwards        Pages: 114
    "This report will be delivered in 2-3 business days after the order is placed." The Clinical Mass Spectrometry market size will be XX million (USD) in 2022 in Philippines, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In Philippines market, the top players include - Thermo Fisher - AB Sciex (Danaher) - Waters - Agilent - Bruker - Perkin Elmer - Shi......
  • 2017-2022 Malaysia Clinical Mass Spectrometry Market Report (Status and Outlook)
    Published: 25-May-2017        Price: US 3360 Onwards        Pages: 114
    "This report will be delivered in 2-3 business days after the order is placed." The Clinical Mass Spectrometry market size will be XX million (USD) in 2022 in Malaysia, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In Malaysia market, the top players include - Thermo Fisher - AB Sciex (Danaher) - Waters - Agilent - Bruker - Perkin Elmer - Shidmazu......
  • 2017-2022 Japan Clinical Mass Spectrometry Market Report (Status and Outlook)
    Published: 25-May-2017        Price: US 3360 Onwards        Pages: 114
    "This report will be delivered in 2-3 business days after the order is placed." The Clinical Mass Spectrometry market size will be XX million (USD) in 2022 in Japan, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In Japan market, the top players include - Thermo Fisher - AB Sciex (Danaher) - Waters - Agilent - Bruker - Perkin Elmer - Shidmazu ......
  • 2017-2022 India Clinical Mass Spectrometry Market Report (Status and Outlook)
    Published: 25-May-2017        Price: US 3360 Onwards        Pages: 114
    "This report will be delivered in 2-3 business days after the order is placed." The Clinical Mass Spectrometry market size will be XX million (USD) in 2022 in India, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In India market, the top players include - Thermo Fisher - AB Sciex (Danaher) - Waters - Agilent - Bruker - Perkin Elmer - Shidmazu ......
  • 2017-2022 China Clinical Mass Spectrometry Market Report (Status and Outlook)
    Published: 25-May-2017        Price: US 3360 Onwards        Pages: 114
    "This report will be delivered in 2-3 business days after the order is placed." The Clinical Mass Spectrometry market size will be XX million (USD) in 2022 in China, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In China market, the top players include - Thermo Fisher - AB Sciex (Danaher) - Waters - Agilent - Bruker - Perkin Elmer - Shidmazu ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs